NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS

Clinical trials for NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS explained in plain language.

Never miss a new study

Get alerted when new NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS trials appear

Sign up with your email to follow new studies for NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Last-Resort drug offered for patients with untreatable infections

Disease control AVAILABLE

This program provides access to the drug Clofazimine for adults with serious Non-Tuberculous Mycobacterial (NTM) infections that have not responded to standard treatments. The drug is approved for leprosy but is being made available here for patients who have run out of other opt…

Matched conditions: NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 02, 2026 02:42 UTC

NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS

Get alerted when new NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS trials appear

Last-Resort drug offered for patients with untreatable infections